Two Sigma Securities, LLC Standard Biotools Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.65 - $2.92 $18,159 - $32,137	11,006 Added 67.84%	27,230 $48,000
Q1 2024 May 15, 2024	SELL	$1.87 - $2.78 $6,975 - $10,369	-3,730 Reduced 18.69%	16,224 $43,000
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $31,726 - $54,474	19,954 New	19,954 $44,000
Q1 2023 May 15, 2023	BUY	$1.3 - $2.24 $14,318 - $24,671	11,014 New	11,014 $21,000
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.99 $18,502 - $46,140	11,564 New	11,564 $19,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.